Company intelligence / Profile preview

Winback

Ownership: Private
Development stage: Commercial

Overview

Winback’s technologies are widely used in physiotherapy clinics worldwide. Clinical testimonials report rapid recovery times and significant improvements in mobility and pain reduction across acute/chronic musculoskeletal conditions. The company claims high satisfaction rates among both therapists (~95%) and patients (~91% reporting immediate/lasting outcomes), based on user surveys. No formal drug-like clinical trial data as the products are medical devices.

Therapeutic areas: OtherRheumatologyNeurology
Modalities: DeviceNon-pharmacological therapyElectrotherapy (TECAR therapy)ThermotherapyCompression therapy
Industry: Therapeutic Medical Devices

Partnerships

Endorsed by top hospitals such as Johns Hopkins HospitalCollaborations with professional sports organizationsNo major pharma partnerships reported

Beyond the preview

Go deeper on Winback.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Winback.

Explore the full profile